Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CYCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CYCC

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 13.07.2016

Cyclacel Pharmaceuticals Inc

CYCC
Current price
13.07 USD +5.07 USD (+63.38%)
Last closed 8.20 USD
ISIN US23254L6039
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 12 988 472 USD
Yield for 12 month -96.74 %
1Y
3Y
5Y
10Y
15Y
CYCC
21.11.2021 - 28.11.2021

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. Address: Level 10, Kuala Lumpur, Malaysia, 592000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.00 USD

P/E Ratio

0.19

Dividend Yield

Financials CYCC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CYCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+43 000 USD

Last Year

+420 000 USD

Current Quarter

-35 000 USD

Last Quarter

Current Year

+37 000 USD

Last Year

+420 000 USD

Current Quarter

-39 000 USD

Last Quarter

EBITDA -12 679 500 USD
Operating Margin TTM -90 607.14 %
Price to Earnings 0.19
Return On Assets TTM -160.18 %
PEG Ratio
Return On Equity TTM -1 950.23 %
Wall Street Target Price 1.00 USD
Revenue TTM 14 000 USD
Book Value 3.54 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM 14 000 USD
Earnings per share 43.20 USD
Diluted Eps TTM 43.20 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CYCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.19
Forward PE
Enterprise Value Revenue 128.71
Price Sales TTM 927.75
Enterprise Value EBITDA 0.018
Price Book MRQ 1.71

Technical Indicators CYCC

For 52 Weeks

3.08 USD 283.40 USD
50 Day MA 21.91 USD
Shares Short Prior Month 595 114
200 Day MA 86.34 USD
Short Ratio 0.26
Shares Short 19 649
Short Percent 81.68 %